NASDAQ:DCPH
Deciphera Pharmaceuticals Inc Stock News
$25.46
+0.0100 (+0.0393%)
At Close: May 17, 2024
Riverside and Corn Exchange need £2m and £250k to repair roofs
06:56pm, Friday, 05'th Jun 2020
Riverside sports centre roof repairs, upgrading CCTV and installing 'anti-traveller' measures at Exeter green spaces will happen when finances allow
An empirical evaluation of large dynamic covariance models in portfolio value-at-risk estimation - Journal of Risk Model Validation
12:14pm, Thursday, 04'th Jun 2020
This research develops a framework adopting conditional covariance modeling combined with various de-noising methods to estimate the portfolio VaR and proves
Boardroom shuffles become latest coping mechanism for companies battling COVID-19 fallout
12:50pm, Wednesday, 03'rd Jun 2020
The CEO revolving door is spinning fast as U.K.-listed companies try to cope with the coronavirus crisis.
The Debate Is Over: This Cancer Stock Is Winning the GIST Race
11:11am, Wednesday, 03'rd Jun 2020
Blueprint Medicines and Deciphera Pharmaceuticals were going toe-to-toe developing treatments for this rare cancer. Investors can now call the winner.
Disability charities that support millions could close without emergency funds
11:00pm, Monday, 01'st Jun 2020
DisabilityCharityConsortium(DCC) members say there has been no coherent strategy to support the UK's 14 million disabled people through the coronavirus pandemic
Dramatic U-turn on plans to close seven Derbyshire care homes
08:12pm, Monday, 01'st Jun 2020
Several care homes could have closed during the pandemic
Case registered against Ramesh Chennithala, 20 other Congress leaders for violating lockdown in Kerala
09:44pm, Sunday, 31'st May 2020
A case has been registered against opposition leader Ramesh Chennithala among 20 other Congress workers for violating social distancing norms and lockdown guidelines to participate in agitation in Tho
FRSC board approves promotion of 42 senior officers
09:58am, Saturday, 30'th May 2020
The board of the Federal Road Safety Commission (FRSC) has approved the promotion of 10 Corps Commanders (CC) to the rank of Assistant Corps Marshal (ACM) and 32 Deputy Corps Commanders (DCC) to th…
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) today announced the presentation of data from the endometrial cancer cohort of Part 2 of its ongoing Phase 1b/2 clinical trial of rebastinib, the Company�
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) today announced the presentation of quality of life and certain safety results from the INVICTUS pivotal Phase 3 study evaluating QINLOCK™ (ripretinib)
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) today announced the presentation of quality of life and certain safety results from the INVICTUS pivotal
Anger as Devon Highways van displays 'virus hoax' posters in windows
03:29pm, Thursday, 28'th May 2020
The van had posters on it saying things like 'Plandemic', 'Illuminati' and 'virus hoax'
Deciphera Pharmaceuticals to Present at the Jefferies 2020 Healthcare Conference
11:00am, Wednesday, 27'th May 2020
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), a commercial biopharmaceutical company addressing key mechanisms of tumor drug resistance, today announced that Steve Hoerter, President and Chief Execut
News Flash: Analysts Just Made A Captivating Upgrade To Their Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Forecasts
11:06am, Tuesday, 26'th May 2020
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) shareholders will have a reason to smile today, with the analysts making...
AmerisourceBergen Selected by Deciphera Pharmaceuticals to Support QINLOCK™
12:00am, Tuesday, 26'th May 2020
AmerisourceBergen, a global healthcare solutions leader, announced today that it has been selected by Deciphera Pharmaceuticals (Deciphera) to support
